Cargando…
Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection
For the last few decades, Calcineurin inhibitors (CNI)-based therapy has been the pillar of immunosuppression for prevention of organ transplant rejection. However, despite exerting effective control of acute rejection in the first year post-transplant, prolonged CNI use is associated with significa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478663/ https://www.ncbi.nlm.nih.gov/pubmed/36119093 http://dx.doi.org/10.3389/fimmu.2022.926648 |